Govt should relax vaccine price controls to boost innovation and growth: Serum's Adar Poonawalla

Top Post Ad

Speaking to CNBC-TV18’s Shereen Bhan at Davos 2025, Adar Poonawalla, CEO of the Serum Institute of India, emphasised the need for balanced reforms that maintain affordability while enabling companies to generate sufficient profits for reinvestment and research. “I think the government has to re-look at and relax some of the price controls that we have,” Poonawalla said.

from Video News in CNBCTV18, Video Latest News, Video News https://ift.tt/CX5f0SO